Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Wechsler

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Epilepsy & Behavior : E&B|December 5, 2017
Optimizing clobazam treatment in patients with Lennox-Gastaut syndromeJouko Isojarvi, Barry E Gidal, Steve Chung, et al.
Epilepsia|August 17, 2016
Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trialDavid G Vossler, Robert T Wechsler, Paulette Williams, et al.
Epilepsy & Behavior Reports|November 3, 2025
Long-term efficacy and safety of perampanel in patients aged 60 years and older with focal seizures: Post hoc analysis of phase III open-label extension studies stratified by enzyme-inducing anti-seizure medication useRohit Marawar, Ilo E Leppik, Robert T Wechsler, et al.
Epilepsia Open|March 8, 2021
Perampanel in real-world clinical care of patients with epilepsy: Interim analysis of a phase IV studyJames Wheless, Robert T Wechsler, Marcelo Lancman, et al.
Epilepsy & Behavior : E&B|September 23, 2022
Perampanel monotherapy for the treatment of epilepsy: Clinical trial and real-world evidenceTakamichi Yamamoto, Antonio Gil-Nagel, James W Wheless, et al.
Epilepsy Research|January 25, 2015
Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trialsIlo E Leppik, Robert T Wechsler, Betsy Williams, et al.
Epilepsy Research|January 14, 2017
Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extensionRobert T Wechsler, Stephen L Yates, John Messenheimer, et al.
Epilepsy & Behavior Case Reports|March 16, 2016
Challenges in identifying Lennox-Gastaut syndrome in adults: A case series illustrating its changing natureJesus Eric Piña-Garza, Steve Chung, Georgia D Montouris, et al.
Epilepsy Research|May 22, 2021
A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanelGregory L Krauss, Elinor Ben-Menachem, Robert T Wechsler, et al.
Epilepsia|June 12, 2014
Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind studyRobert T Wechsler, George Li, Jacqueline French, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Epilepsy & Behavior : E&B|December 5, 2017
Optimizing clobazam treatment in patients with Lennox-Gastaut syndromeJouko Isojarvi, Barry E Gidal, Steve Chung, et al.
Epilepsia|August 17, 2016
Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trialDavid G Vossler, Robert T Wechsler, Paulette Williams, et al.
Epilepsy & Behavior Reports|November 3, 2025
Long-term efficacy and safety of perampanel in patients aged 60 years and older with focal seizures: Post hoc analysis of phase III open-label extension studies stratified by enzyme-inducing anti-seizure medication useRohit Marawar, Ilo E Leppik, Robert T Wechsler, et al.
Epilepsia Open|March 8, 2021
Perampanel in real-world clinical care of patients with epilepsy: Interim analysis of a phase IV studyJames Wheless, Robert T Wechsler, Marcelo Lancman, et al.
Epilepsy & Behavior : E&B|September 23, 2022
Perampanel monotherapy for the treatment of epilepsy: Clinical trial and real-world evidenceTakamichi Yamamoto, Antonio Gil-Nagel, James W Wheless, et al.
Epilepsy Research|January 25, 2015
Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trialsIlo E Leppik, Robert T Wechsler, Betsy Williams, et al.
Epilepsy Research|January 14, 2017
Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extensionRobert T Wechsler, Stephen L Yates, John Messenheimer, et al.
Epilepsy & Behavior Case Reports|March 16, 2016
Challenges in identifying Lennox-Gastaut syndrome in adults: A case series illustrating its changing natureJesus Eric Piña-Garza, Steve Chung, Georgia D Montouris, et al.
Epilepsy Research|May 22, 2021
A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanelGregory L Krauss, Elinor Ben-Menachem, Robert T Wechsler, et al.
Epilepsia|June 12, 2014
Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind studyRobert T Wechsler, George Li, Jacqueline French, et al.
Pageof 3